Financhill
Buy
66

DNTH Quote, Financials, Valuation and Earnings

Last price:
$42.65
Seasonality move :
57.98%
Day range:
$42.02 - $43.72
52-week range:
$13.37 - $45.46
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
499.89x
P/B ratio:
3.34x
Volume:
555K
Avg. volume:
812.8K
1-year change:
83.82%
Market cap:
$1.8B
Revenue:
$6.2M
EPS (TTM):
-$3.49

DNTH Analysts' Consensus Rating

The 13 analysts providing 12-month price projections for Dianthus Therapeutics, Inc. shares anticipate an average target of $63.05, ranging from a low estimate of $46.00 to a high estimate of $100.00. This average target implies a growth of 47.96% compared to the current stock price of $42.61.

Consensus Price Target

$63.05

Highest Price Target

$100.00

Lowest Price Target

$46.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 10 13 13

Hold 0 0 0

Sell 0 0 0
Consensus Buy Buy Buy

DNTH Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 3.24% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 1.39% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock